The pill has also been approved for those at high risk for progression to severe Covid-19, including hospitalisation or death.
New York: US pharmaceutical company Pfizer has begun Phase 1 clinical trial of a novel oral antiviral drug for SARS-CoV-2, the virus that causes Covid-19. The oral antiviral clinical candidate “PF-07321332”, a SARS-CoV2-3CL protease inhibitor, has demonstrated potent in vitro anti-viral activity against SARS-CoV-2, as well as activity against other coronaviruses, the company said in […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.